Neocis Stock

neocis.comHealthcare / Medical DevicesFounded: 2012Funding to Date: $171.83MM

Neocis is a robotic technology developer for dental implant surgery. With a mission to allow dentists to plan surgical procedures, Neocis developed a robotic surgical system called Yomi to guide their work during surgeries. Specialties of the company include digital dentistry, digital surgery, and medical robotics. Neocis was founded by Alon Mozes and Juan Salcedo in 2009 and is headquartered in Miami, Fl.

Register To Buy and Sell Shares

For more details on financing and valuation for Neocis, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Neocis’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Neocis.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.

Neocis investors also invested in these private companies

Norwest Venture Partners
Mithril Capital Management
MedTech Innovator
Intuitive Ventures
HealthTech Capital
Denso Corporate Ventures
Care Capital
Courtney Ventures
Florida Opportunity Fund
Mirae Asset Venture Investment
Bio/Med Investor Network
CLI Ventures
Synergy Ventures


Management Team

Alon Mozes Ph.D
Co-Founder, President & Chief Executive Officer
Juan Salcedo
Co-Founder, Research & Development & Vice President of Operations

Board Members

Ajay Royan
Mithril Capital Management
Casper de Clercq
Norwest Venture Partners
Oliver Keown MD
Intuitive Ventures
Randall Glein
DFJ Growth

Neocis’ stock FAQs


Can you buy Neocis’ stock?

Neocis is not publicly traded on NYSE or NASDAQ in the U.S. To buy Neocis’ stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Can you sell Neocis’ stock?

Yes, you can sell stock of a private company like Neocis. Forge can help you sell your Neocis stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.

What is Neocis’ stock price?

Neocis is a privately held company and therefore does not have a public stock price. However, you may access Neocis’ private market stock price with Forge Data.

What is Neocis’ stock ticker symbol?

Neocis does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Neocis brings in $20M for robotic dental surgeries

Neocis, which has developed the Yomi robot to assist in dental implant surgeries, has brought in $20 million in funding. The Miami-based company plans to use the funding for business initiatives including product development, sales enablement, and clinical education. “The latest investment is a testament to our growth as a company and how far dental robotics has come since the first Yomi systems were installed,” stated Alon Mozes, Neocis’ co-founder and CEO, in a release.
Updated on: Jun 21, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.